Global Market for 3D Cell Cultures to Reach $2.2 Billion in 2019; Explosive Market Expansion Forecasted
January 21, 2015
Wellesley, Mass., January 21, 2015 –BCC Research (www.bccresearch.com) reveals in its new report, 3D Cell Cultures: Technologies and Global Markets, the global three-dimensional (3D) cell culture market is expected to grow to $2.2 billion by 2019, with a five-year compound annual growth rate (CAGR) of 30.1%.
Significant growth within the biopharmaceuticals industry is spurring unprecedented innovation and demand for cell culture products for the purposes of drug discovery and safety testing. While 2D cell cultures have been in laboratory use since the 1950s, the market for 3D cultures, which more accurately model human tissue in vivo without utilizing animal test subjects, has witnessed spectacular growth over the past decade. Indeed, this market is poised to experience explosive growth within the forecast period, as well as create fertile ground for consolidations, mergers, and acquisitions for many types and sizes of companies.
Fueled by toxicity testing and increased biopharmaceutical production, the assay kits category is the fastest moving segment of the overall market, moving at a tremendous 42% CAGR. Demand in this area is driven by the fact that assay kits contain all the necessary reagents and specific protocols packaged for laboratory use.
With 57% market share in 2013, the cells and tissues category is the largest segment of the overall 3D cultures market. This segment, which includes reagents, media and sera, is predicted to reach $1.15 billion in 2019 and register a significant 27.5% CAGR.
Meanwhile, the 3D technologies segment, which includes gels, scaffolds, bioreactors, hanging droplet platforms for spheroid growth and microchips often used to create so-called "homebrew" assay kits, is anticipated to register a healthy 27.8% CAGR.
“Growth in this industry will be driven by rising R&D spending for products such as antibodies and vaccines, soaring biopharmaceutical production, and increasing instances of cancer and liver-related issues,” said BCC Research biotechnology analyst Robert Hunter. “Indeed, these rising rates combined with improved access to consumer healthcare in the United States as well as in emerging markets such as China and India, are expected to spur exceptional growth in the 3D cell cultures market for the foreseeable future.”
Mr. Hunter will present a free webcast, 3D Cell Culture Market Accelerates into Hyper-drive, on January 28 at 12:00 p.m., U.S. Eastern time to discuss this exciting market. Click here to register.
3D Cell Cultures: Technologies and Global Markets provides an overview of the global market for 3D cell culture and related technologies. It includes analyses of global market trends, with data from 2013 and 2014, and projections through 2019.

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.
3D Cell Cultures: Technologies and Global Markets( BIO140A )
Publish Date: Dec 2014
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biomarker Deals Accelerate: Strategic Alliances Reshape Life Sciences Innovation
- China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030
- mRNA Market Forecast: Small Decline of -0.04% CAGR by 2030
- Molecular Diagnostics Market to Grow at 13.1% CAGR Through 2030
- Biotech Equipment Market Projected to Reach $143.9 Billion Globally by 2030
Reports from Cell Biology
Recent News
- Global Hyaluronic Acid in Healthcare Market to Reach $10.5 Billion by 2030
- Global Patient Monitoring Market to Reach $55.8 Billion by End of 2030
- Global Market for Biological and Medical Imaging Reagents Set to Surge to $40.1 Billion by 2030
- Targeted Alpha Therapies Market to Grow at 44% CAGR Globally by 2030
- Global Anti-Parkinson's Drugs Markets Projected to Reach $9.2 Billion by the End of 2030
